Partner Headlines - LLY

  1. AstraZeneca's Onglyza Ups Risk Of Death, FDA Says

    IBD
  2. 5 'Key Pipeline Catalysts' To Watch At Eli Lilly

    Benzinga
  3. Can Veeva Systems' Software Keep Luring Big Pharma?

    IBD
  4. IPO Alert: Biotech Investors Should Watch Advanced Accelerator's ...

    Benzinga
  5. UBS: Eli Lilly's 'Outlook Continuing To Improve'

    Benzinga
  6. Eli Lilly CEO Explains The Reasons Behind Not Changing 2015 Guidance ...

    Benzinga
  7. Viekira Pak View Falls Short

    IBD
  8. AbbVie Beats, But Stock Falls; Lilly Cuts Guidance

    IBD
  9. UPDATE: Eli Lilly Posts Upbeat Q4 Profit, Sales Decline

    Benzinga
  10. Earnings Scheduled For January 30, 2015

    Benzinga
  11. 10 Must Watch Stocks for Today

    Benzinga
  12. Box Ready To Unwrap IPO In Hot Online Storage Field

    IBD
  13. Feeling Good With This Med Company

    GuruFocus
  14. Eli Lilly

    IBD
  15. Here Is Goldman Sachs' Potential Pair Trade For 2 Drug Giants

    Benzinga
  16. 10 Biotech Stories You Might've Missed This Week

    Benzinga
  17. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD
  18. Exclusive: JPMorgan Chase CEO Jamie Dimon Talks Cancer Recovery, ...

    FoxBusiness
  19. Eil Lilly CEO Talks New Product Launches, Pricing Pressure From ...

    Benzinga
  20. FDA Issues Import Block On Eli Lilly's Cialis

    Benzinga
  21. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  22. Deutsche Bank, Stifel Differ On Outlook For Eli Lilly

    Benzinga
  23. Benzinga's Top Upgrades

    Benzinga
  24. Jefferies Upgrades Eli Lilly To Buy

    Benzinga
  25. UPDATE: Deutsche Bank Downgrades Eli Lilly On Positive Outlook, ...

    Benzinga
  26. Eli Lilly

    IBD
  27. Alkermes Hits High On Schizophrenia Drug Results

    IBD
  28. Eli Lilly Moves Higher Following FY 2014 & 2015 Outlook

    Benzinga
  29. Benzinga's Top #PreMarket Losers

    Benzinga
  30. Fast Money Halftime Report Final Trade From January 6

    Benzinga
  31. US Stock Futures Surge Ahead Of Manufacturing Data

    Benzinga
  32. Roche Drugs For Alzheimer's, Breast Cancer Disappoint

    IBD
  33. 7 Stocks You Should Be Watching Today

    Benzinga
  34. Eli Lilly

    IBD
  35. Lilly Upgraded On 2 Potential Blockbuster Drugs

    IBD
  36. Alexandria Real Estate REIT Inks Rx For Pharma Boom

    IBD
  37. Biogen Alzheimer's Drug Succeeding In Early Tests

    IBD
  38. Zosano Pharma and Eli Lilly and Company Enter Into Exclusive ...

    Benzinga
  39. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD
  40. Screening Pharma Stocks Amid Turnaround

    YCharts
  41. Sarah Ketterer Dives in when Others Pull Out

    GuruFocus
  42. Credit Suisse Raises Eli Lilly Price Target

    Benzinga
  43. Veeva Systems Flies High On Cloud For Life Sciences

    IBD
  44. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD
  45. French Drugmaker Sanofi Warns Of Tougher Competition

    IBD
  46. US Stock Futures Rise Ahead Of Earnings, Economic Data

    Benzinga
  47. Earnings Scheduled For October 23, 2014

    Benzinga
  48. CANDA NK-2 Files Motion To Dismiss Patent Infringement Suit

    Benzinga
  49. Lilly, Zymeworks Announce Expansion Of Strategic Licensing And ...

    Benzinga
  50. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga
  51. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD
  52. UPDATE: Lilly To Initiate Efforts To Sell Guayama Site

    Benzinga
  53. Lilly Announces Plan to Realign Puerto Rico Manufacturing Operations

    Benzinga
  54. Drug Analysts Mull End Of 'Double Irish' Loophole

    IBD
  55. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts
  56. Meet 5 Top International Stocks Not Based In China

    IBD
  57. Dyax Offers Highlights of Recent Progress in Licensing, Funded-Research ...

    Benzinga
  58. Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone

    Benzinga
  59. Drug giants target Alzheimer's

    IBD
  60. What Is A High Risk Market?

    Benzinga
  61. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt ...

    GuruFocus
  62. Markets Little Changed In Low Volume And Slow News Ahead Of Long ...

    Benzinga
  63. Deutsche Bank: Eli Lilly At 'Critical Stage' In Its Journey

    Benzinga
  64. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers ...

    Benzinga
  65. New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now ...

    Benzinga
  66. UPDATE: Tigress Initiates Coverage On Eli Lilly

    Benzinga
  67. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  68. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical ...

    Benzinga
  69. Thursday Morning Earnings Reports

    Benzinga
  70. Earnings Scheduled For July 24, 2014

    Benzinga
  71. New Study Shows Beta-Amyloid Imaging Is Associated With Altered ...

    Benzinga
  72. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover ...

    Benzinga
  73. Benzinga's Top #PreMarket Gainers

    Benzinga
  74. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga
  75. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  76. UPDATE: Barclays Upgrades Eli Lilly Despite Sector Downgrade

    Benzinga
  77. Benzinga's Top Upgrades

    Benzinga
  78. Eli Lilly is on the Right Track

    GuruFocus
  79. Celgene Sees Better Results For Psoriatic Arthritis

    IBD
  80. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  81. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  82. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  83. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  84. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  85. Lilly Says Abemaciclib in Phase 1 Study Demonstrated Single-Agent ...

    Benzinga
  86. Eli Lilly insulin trial succeeds

    IBD
  87. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  88. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  89. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
  90. UPDATE: Eli Lilly Announces Peglispro Shows Superiority Compared ...

    Benzinga
  91. Can Pfizer Make Up Its Loss?

    GuruFocus
  92. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  93. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  94. Will Pfizer's Q1 2014 Earnings Beat the Street on May 5, 2014?

    GuruFocus
  95. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  96. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  97. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  98. Vanguard Health Care Fund's Top Quarterly Holdings

    GuruFocus
  99. Actavis Earns Over-The-Top Q1

    IBD
  100. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
Trading Center